Global Orally Disintegrating Tablet market is reach 24400$ M by the end of 2025, growing at a CAGR of 10.2%
This report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market
Pune, India – July 3, 2018 /MarketersMedia/ —
The global Orally Disintegrating Tablet market is valued at 11200 million US$ in 2017 and will reach 24400 million US$ by the end of 2025, growing at a CAGR of 10.2% during 2018-2025.
The classification of Orally Disintegrating Tablet includes Anti-Psychotics Drug, Anti-Epileptics Drug and others, and the proportion of Anti-Psychotics Drug in 2017 is about 16.6%, Anti-Psychotics drug class will be the reigning segment in terms of market revenue share throughout the forecast period, anticipated to hold about 20.3% revenue share of the global market by 2025 end. With a noteworthy 15.7% CAGR, this segment will retain its supremacy over other drug class segments during the eight-year period.
Under by Disease Indication, the global market is segmented into Central Nervous System (CNS) Diseases, Gastrointestinal (GI) Diseases, Cardiovascular (CVS) Diseases and Others. CNS Diseases segment will hold maximum revenue share in the global market, and the consumption proportion is about 53.4% in 2017. and forecasts indicate a 57.2% market share for this segment by the end of the forecast period in 2025.
North America is the largest consumption place, with a consumption market share nearly 40.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 31.6%, China is also an important sales region for the Orally Disintegrating Tablet.
Access this report at: https://www.themarketreports.com/report/global-orally-disintegrating-tablet-market-research-report-2018
Companies profiled in this report are Teva, Merck, Mylan, Pfizer, Johnson And Johnson, Gsk, Otsuka, Eli Lilly And Company, Astrazeneca, Bristol-Myers Squibb, Conquer and more.
Analysis by Product Types, with production, revenue, price, market share and growth rate of each type, can be divided into
• Anti-Psychotics Drug
• Anti-Epileptics Drug
• Other
Analysis by Applications, this report focuses on consumption, market share and growth rate of Orally Disintegrating Tablet in each application, can be divided into
• CNS Diseases
• Gastrointestinal Diseases
• CVS Diseases
• Other
Purchase this premium research report at: https://www.themarketreports.com/report/buy-now/942129
Table of Contents:
1 Orally Disintegrating Tablet Market Overview
2 Global Orally Disintegrating Tablet Market Competition by Manufacturers
3 Global Orally Disintegrating Tablet Capacity, Production, Revenue (Value) by Regions (2013-2018)
4 Global Orally Disintegrating Tablet Supply (Production), Consumption, Export, Import by Regions (2013-2018)
5 Global Orally Disintegrating Tablet Production, Revenue (Value), Price Trend by Types
6 Global Orally Disintegrating Tablet Market Analysis by Applications
7 Global Orally Disintegrating Tablet Manufacturers Profiles/Analysis
8 Orally Disintegrating Tablet Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
11 Market Effect Factors Analysis
12 Global Orally Disintegrating Tablet Market Forecast (2018-2025)
13 Research Findings and Conclusion
14 Appendix
Inquire more about this report at: https://www.themarketreports.com/report/ask-your-query/942129
Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, North Block, Sacred World, Wanawadi
Phone: +1-631-407-1315
For more information, please visit https://www.themarketreports.com/report/global-orally-disintegrating-tablet-market-research-report-2018
Source: MarketersMedia
Release ID: 370864
Copyright © 1999-2013 SproutNews.com
